Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of intravenous vancomycin use in pediatric patients
ChiCTR1900022308Phase 4Not yet recruiting
- Sponsor
- Zhengzhou Children's Hospital
- Start
- Apr 2019
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vancomycin in Infectious disease, sponsored by Zhengzhou Children's Hospital. Primary endpoints: Rate of vancomycin trough concentrations within the desired target range and Adverse events during vancomycin treatment. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
vancomycin
03
Conditions
Infectious disease
Beyond the preview
Go deeper on ChiCTR1900022308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022308.